1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Global Market by Source 43
3.1 Market Overview by Source 43
3.2 Human 45
3.3 Humanized 46
3.4 Chimeric 47
3.5 Murine 48
4 Segmentation of Global Market by Category 49
4.1 Market Overview by Category 49
4.2 Branded mAbs 51
4.3 Biosimilar mAbs 52
5 Segmentation of Global Market by Production Type 53
5.1 Market Overview by Production Type 53
5.2 In Vitro Production 55
5.3 In Vivo Production 56
6 Segmentation of Global Market by Application 57
6.1 Market Overview by Application 57
6.2 Cancer 59
6.2.1 Breast Cancer 61
6.2.2 Colorectal Cancer 62
6.2.3 Lung Cancer 63
6.2.4 Ovarian Cancer 64
6.2.5 Other Cancer Types 65
6.3 Autoimmune Diseases 66
6.4 Inflammatory Diseases 67
6.5 Infectious Diseases 68
6.6 Other Applications 69
7 Segmentation of Global Market by End User 70
7.1 Market Overview by End User 70
7.2 Hospitals 72
7.3 Research Institutes 73
7.4 Other End Users 74
8 Segmentation of Global Market by Region 75
8.1 Geographic Market Overview 2019-2030 75
8.2 North America Market 2019-2030 by Country 79
8.2.1 Overview of North America Market 79
8.2.2 U.S. 83
8.2.3 Canada 86
8.2.4 Mexico 88
8.3 European Market 2019-2030 by Country 90
8.3.1 Overview of European Market 90
8.3.2 Germany 94
8.3.3 U.K. 96
8.3.4 France 98
8.3.5 Spain 100
8.3.6 Italy 102
8.3.7 Russia 104
8.3.8 Rest of European Market 106
8.4 Asia-Pacific Market 2019-2030 by Country 108
8.4.1 Overview of Asia-Pacific Market 108
8.4.2 Japan 112
8.4.3 China 115
8.4.4 Australia 117
8.4.5 India 119
8.4.6 South Korea 121
8.4.7 Rest of APAC Region 123
8.5 South America Market 2019-2030 by Country 125
8.5.1 Argentina 128
8.5.2 Brazil 130
8.5.3 Chile 132
8.5.4 Rest of South America Market 134
8.6 MEA Market 2019-2030 by Country 135
8.6.1 UAE 138
8.6.2 Saudi Arabia 140
8.6.3 South Africa 142
8.6.4 Other National Markets 144
9 Competitive Landscape 145
9.1 Overview of Key Vendors 145
9.2 New Product Launch, Partnership, Investment, and M&A 148
9.3 Company Profiles 149
Abbott Laboratories 149
AbbVie, Inc. 151
Amgen Inc. 152
AstraZeneca plc 153
Bayer AG 154
Bristol-Myers Squibb Company 155
Eli Lilly 156
F. Hoffmann-La Roche Ltd. 157
GlaxoSmithKline Plc 158
Johnson & Johnson 159
Merck & Co., Inc. 160
Mylan N.V 161
Norvatis AG 162
Pfizer 163
Sanofi S.A. 164
RELATED REPORTS 165